Analysis of reversions in the 5′-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines

Journal of Infectious Diseases

Volumn 193, Issue 10, 2006, Pages 1344-1349

  Laassri, Majid ^a   Lottenbach, Kathleen ^c   Belshe, Robert ^c   Rennels, Margaret ^b   Plotkin, Stanley ^d   Chumakov, Konstantin ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INACTIVATED VIRUS VACCINE; IPOL; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

5' UNTRANSLATED REGION; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUROTOXICITY; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; POLIOMYELITIS VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVERTANT; SEROTYPE; VACCINATION; VIRUS GENOME; VIRUS REPLICATION; VIRUS VIRULENCE;

DNA, VIRAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UNTRANSLATED REGIONS; VACCINATION; VIRUS SHEDDING;

EID: 33646338201     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/503366     Document Type: Article

References (25)

1. Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992; 14:568-79.
2. Centers for Disease Control and Prevention. Certification of poliomyelitis eradication-European Region, June 2002. MMWR Morb Mortal Wkly Rep 2002; 51:572-4.
3. Ghendon Y, Robertson SE. Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. Bull World Health Organ 1994; 72:973-83.
4. Prevots DR, Strebel PM. Poliomyelitis prevention in the United States: new recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine. Pediatr Ann 1997; 26:378-83.
5. Cann AJ, Stanway G, Hughes PJ, et al. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res 1984; 12:7787-92.
6. Friedrich F. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees. Acta Virol 1996; 40:157-70.
7. Minor PD. The molecular biology of poliovaccines. J Gen Virol 1992; 73:3065-77.
8. Macadam AJ, Pollard SR, Ferguson G, et al. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 1993; 192:18-26.
9. Otelea D, Guillot S, Furione M, et al. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses. Dev Biol Stand 1993; 78:33-8.
10. Svitkin YV, Cammack N, Minor PD, Almond JW. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U. Virology 1990; 175:103-9.
11. Guest S, Pilipenko E, Sharma K, Chumakov K, Roos RP. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol 2004;78:11097-107.
12. Abraham R, Minor P, Dunn G, Modlin JF, Ogra PL. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. J Infect Dis 1993; 168:1105-9.
13. Dunn G, Begg NT, Cammack N, Minor PD. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol 1990; 32:92-5.
14. Centers for Disease Control and Prevention. Circulation of a type 2 vaccine-derived poliovirus- Egypt, 1982-1993. MMWR Morb Mortal Wkly Rep 2001; 50:41-42, 51.
15. Centers for Disease Control and Prevention. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus, Philippines, 2001. Wkly Epidemiol Rec 2001; 76:319-20.
16. Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002; 296:3 56-9.
17. Centers for Disease Control and Prevention. Paralytic poliomyelitis in Madagascar, 2002. Wkly Epidemiol Rec 2002; 77:241-2.
18. Ogra PL, Faden HS, Abraham R, Duffy LC, Sun M, Minor PD. Effect of prior immunity on the shedding of virulent revenant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis 1991; 164:191-4.
19. Laassri M, Dragunsky E, Enterline J, et al. Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J Clin Microbiol 2005; 43:2886-94.
20. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1997; 99:300-5.
21. Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine; recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997;46(RR-3):1-25.
22. Laassri M, Lottenbach K, Belshe R, et al. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis 2005; 192:2092-8.
23. Rennels MB, Englund JA, Bernstein DI, et al. Diminution of the antipolyribosylribitol phosphate response to a combined diphtheria-tetanus- acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination. Pediatr Infect Dis J 2000; 19:417-23.
24. Minor PD, Dunn G. The effect of sequences in the 5′ non-coding region on the replication of polioviruses in the human gut. J Gen Virol 1988; 69:1091-6.
25. Minor PD, Dunn G, Ramsay ME, Brown D. Effect of different immunization schedules on the excretion and reversion of oral polio vaccine strains. J Med Virol 2005; 75:153-60.